169 related articles for article (PubMed ID: 24884853)
21. [Use of acid-suppressive medications in hospitalized patients].
Noguerado Asensio A; Rodríguez Barrientos R; Zelaya Castro P; Sánchez Sempere A; Antuña Blanco F; Lutz García E; Quintana de la Cruz R; Estellés Piera F; Alcázar MS
An Med Interna; 2002 Nov; 19(11):557-60. PubMed ID: 12522890
[TBL] [Abstract][Full Text] [Related]
22. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
23. Association between pulmonary tuberculosis and acid suppressive agents.
Lai SW; Lin CL; Liao KF
Postgrad Med J; 2020 Mar; 96(1133):165. PubMed ID: 31511318
[No Abstract] [Full Text] [Related]
24. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C
Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806
[TBL] [Abstract][Full Text] [Related]
25. Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events.
Li X; Klompas M; Menchaca JT; Young JG
Infect Control Hosp Epidemiol; 2020 Feb; 41(2):187-193. PubMed ID: 31818336
[TBL] [Abstract][Full Text] [Related]
26. Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan.
Cheng KC; Liao KF; Lin CL; Lai SW
Front Pharmacol; 2017; 8():481. PubMed ID: 28769810
[No Abstract] [Full Text] [Related]
27. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
[TBL] [Abstract][Full Text] [Related]
29. Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
J Pediatr; 2016 Jul; 174():63-70.e3. PubMed ID: 27131401
[TBL] [Abstract][Full Text] [Related]
30. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.
Fan WC; Ou SM; Feng JY; Hu YW; Yeh CM; Su VY; Hu LY; Chien SH; Su WJ; Chen TJ; Liu CJ
Int J Tuberc Lung Dis; 2016 Feb; 20(2):265-70. PubMed ID: 26792483
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of therapeutic effects of PPI and H2RA on ulcers during continuous aspirin therapy.
Nema H; Kato M
World J Gastroenterol; 2010 Nov; 16(42):5342-6. PubMed ID: 21072898
[TBL] [Abstract][Full Text] [Related]
33. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
[TBL] [Abstract][Full Text] [Related]
34. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada.
Tett SE; Sketris I; Cooke C; van Zanten SV; Barozzi N
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):735-43. PubMed ID: 23559528
[TBL] [Abstract][Full Text] [Related]
35. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients.
Glew CM; Rentler RJ
J Am Med Dir Assoc; 2007 Nov; 8(9):607-9. PubMed ID: 17998118
[TBL] [Abstract][Full Text] [Related]
36. Association Between Use of Acid-Suppressive Medications and Antibiotics During Infancy and Allergic Diseases in Early Childhood.
Mitre E; Susi A; Kropp LE; Schwartz DJ; Gorman GH; Nylund CM
JAMA Pediatr; 2018 Jun; 172(6):e180315. PubMed ID: 29610864
[TBL] [Abstract][Full Text] [Related]
37. [Medical treatments of reflux esophagitis - Proton pump inhibitors and histamine H2 receptor antagonists -].
Kinoshita Y; Ishimura N
Nihon Rinsho; 2016 Aug; 74(8):1304-1310. PubMed ID: 30562433
[TBL] [Abstract][Full Text] [Related]
38. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.
Sturkenboom MC; Burke TA; Tangelder MJ; Dieleman JP; Walton S; Goldstein JL
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1137-47. PubMed ID: 14653834
[TBL] [Abstract][Full Text] [Related]
39. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
40. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
